Technical Analysis for SNN - Smith & Nephew SNATS, Inc.

Grade Last Price % Change Price Change
grade A 39.84 -0.13% -0.05
SNN closed down 0.13 percent on Monday, March 25, 2019, on 71 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical SNN trend table...

Date Alert Name Type % Chg
Mar 25 Multiple of Ten Bearish Other 0.00%
Mar 22 Upper Bollinger Band Walk Strength -0.13%
Mar 22 Multiple of Ten Bearish Other -0.13%
Mar 22 Overbought Stochastic Strength -0.13%
Mar 21 Shooting Star Candlestick Bearish -1.19%
Mar 21 Upper Bollinger Band Walk Strength -1.19%
Mar 21 Above Upper BB Strength -1.19%
Mar 21 Overbought Stochastic Strength -1.19%
Mar 21 Up 3 Days in a Row Strength -1.19%
Mar 21 Up 4 Days in a Row Strength -1.19%

Older signals for SNN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company's Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and orthopaedic trauma fixation products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, such as cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company's Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. The company's principal products include ALLEVYN and DURAFIBER branded wound care products; ACTICOAT branded products for infection management; and negative pressure wound therapy products. Smith & Nephew plc primarily serves medical and surgical service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.
Medicine Medical Specialties Surgery Radio Frequency Healthcare Providers Infection Ancillary Products Orthopedic Surgery Medical Device Minimally Invasive Procedures Implant Deformity Sports Medicine Surgical Specialties Burns Minimally Invasive Surgery Surgical Devices Arthroscopy Bone Cement Medicine Products Wound Wound Care Products
Is SNN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 40.78
52 Week Low 32.215
Average Volume 626,106
200-Day Moving Average 36.7617
50-Day Moving Average 38.5566
20-Day Moving Average 39.204
10-Day Moving Average 39.727
Average True Range 0.4547
ADX 29.51
+DI 35.9797
-DI 16.5569
Chandelier Exit (Long, 3 ATRs ) 39.2959
Chandelier Exit (Short, 3 ATRs ) 39.2241
Upper Bollinger Band 40.4112
Lower Bollinger Band 37.9968
Percent B (%b) 0.76
BandWidth 6.158555
MACD Line 0.4608
MACD Signal Line 0.3963
MACD Histogram 0.0645
Fundamentals Value
Market Cap 17.44 Billion
Num Shares 438 Million
EPS 1.96
Price-to-Earnings (P/E) Ratio 20.33
Price-to-Sales 3.57
Price-to-Book 3.97
PEG Ratio 0.00
Dividend 0.62
Dividend Yield 1.56%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.26
Resistance 3 (R3) 40.29 40.19 40.19
Resistance 2 (R2) 40.19 40.08 40.17 40.17
Resistance 1 (R1) 40.01 40.01 39.96 39.98 40.14
Pivot Point 39.91 39.91 39.88 39.89 39.91
Support 1 (S1) 39.73 39.80 39.68 39.70 39.54
Support 2 (S2) 39.63 39.73 39.61 39.51
Support 3 (S3) 39.45 39.63 39.49
Support 4 (S4) 39.42